Controlling the Release of Small, Bioactive Proteins via Dual Mechanisms with Therapeutic Potential

Prathamesh M. Kharkar, Rebecca A. Scott, Laura P. Olney, Paige J. Levalley, Emanual Michael Maverakis, Kristi L. Kiick, April M. Kloxin

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Injectable delivery systems that respond to biologically relevant stimuli present an attractive strategy for tailorable drug release. Here, the design and synthesis of unique polymers are reported for the creation of hydrogels that are formed in situ and degrade in response to clinically relevant endogenous and exogenous stimuli, specifically reducing microenvironments and externally applied light. Hydrogels are formed with polyethylene glycol and heparin-based polymers using a Michael-type addition reaction. The resulting hydrogels are investigated for the local controlled release of low molecular weight proteins (e.g., growth factors and cytokines), which are of interest for regulating various cellular functions and fates in vivo yet remain difficult to deliver. Incorporation of reduction-sensitive linkages and light-degradable linkages affords significant changes in the release profiles of fibroblast growth factor-2 (FGF-2) in the presence of the reducing agent glutathione or light, respectively. The bioactivity of the released FGF-2 is comparable to pristine FGF-2, indicating the ability of these hydrogels to retain the bioactivity of cargo molecules during encapsulation and release. Further, in vivo studies demonstrate degradation-mediated release of FGF-2. Overall, our studies demonstrate the potential of these unique stimuli-responsive chemistries for controlling the local release of low molecular weight proteins in response to clinically relevant stimuli.

Original languageEnglish (US)
JournalAdvanced healthcare materials
DOIs
StateAccepted/In press - 2017

Fingerprint

Hydrogels
Fibroblast Growth Factor 2
Fibroblasts
Proteins
Bioactivity
Light
Polymers
Molecular Weight
Molecular weight
Addition reactions
Reducing Agents
Therapeutics
Encapsulation
Glutathione
Heparin
Reducing agents
Intercellular Signaling Peptides and Proteins
Polyethylene glycols
Cytokines
Degradation

Keywords

  • Biologics delivery
  • Controlled release
  • Injectable hydrogel
  • Responsive materials

ASJC Scopus subject areas

  • Biomaterials
  • Biomedical Engineering
  • Pharmaceutical Science

Cite this

Controlling the Release of Small, Bioactive Proteins via Dual Mechanisms with Therapeutic Potential. / Kharkar, Prathamesh M.; Scott, Rebecca A.; Olney, Laura P.; Levalley, Paige J.; Maverakis, Emanual Michael; Kiick, Kristi L.; Kloxin, April M.

In: Advanced healthcare materials, 2017.

Research output: Contribution to journalArticle

Kharkar, Prathamesh M. ; Scott, Rebecca A. ; Olney, Laura P. ; Levalley, Paige J. ; Maverakis, Emanual Michael ; Kiick, Kristi L. ; Kloxin, April M. / Controlling the Release of Small, Bioactive Proteins via Dual Mechanisms with Therapeutic Potential. In: Advanced healthcare materials. 2017.
@article{c47e05c7d9964510b9c29e0a882e944d,
title = "Controlling the Release of Small, Bioactive Proteins via Dual Mechanisms with Therapeutic Potential",
abstract = "Injectable delivery systems that respond to biologically relevant stimuli present an attractive strategy for tailorable drug release. Here, the design and synthesis of unique polymers are reported for the creation of hydrogels that are formed in situ and degrade in response to clinically relevant endogenous and exogenous stimuli, specifically reducing microenvironments and externally applied light. Hydrogels are formed with polyethylene glycol and heparin-based polymers using a Michael-type addition reaction. The resulting hydrogels are investigated for the local controlled release of low molecular weight proteins (e.g., growth factors and cytokines), which are of interest for regulating various cellular functions and fates in vivo yet remain difficult to deliver. Incorporation of reduction-sensitive linkages and light-degradable linkages affords significant changes in the release profiles of fibroblast growth factor-2 (FGF-2) in the presence of the reducing agent glutathione or light, respectively. The bioactivity of the released FGF-2 is comparable to pristine FGF-2, indicating the ability of these hydrogels to retain the bioactivity of cargo molecules during encapsulation and release. Further, in vivo studies demonstrate degradation-mediated release of FGF-2. Overall, our studies demonstrate the potential of these unique stimuli-responsive chemistries for controlling the local release of low molecular weight proteins in response to clinically relevant stimuli.",
keywords = "Biologics delivery, Controlled release, Injectable hydrogel, Responsive materials",
author = "Kharkar, {Prathamesh M.} and Scott, {Rebecca A.} and Olney, {Laura P.} and Levalley, {Paige J.} and Maverakis, {Emanual Michael} and Kiick, {Kristi L.} and Kloxin, {April M.}",
year = "2017",
doi = "10.1002/adhm.201700713",
language = "English (US)",
journal = "Advanced healthcare materials",
issn = "2192-2640",
publisher = "John Wiley and Sons Ltd",

}

TY - JOUR

T1 - Controlling the Release of Small, Bioactive Proteins via Dual Mechanisms with Therapeutic Potential

AU - Kharkar, Prathamesh M.

AU - Scott, Rebecca A.

AU - Olney, Laura P.

AU - Levalley, Paige J.

AU - Maverakis, Emanual Michael

AU - Kiick, Kristi L.

AU - Kloxin, April M.

PY - 2017

Y1 - 2017

N2 - Injectable delivery systems that respond to biologically relevant stimuli present an attractive strategy for tailorable drug release. Here, the design and synthesis of unique polymers are reported for the creation of hydrogels that are formed in situ and degrade in response to clinically relevant endogenous and exogenous stimuli, specifically reducing microenvironments and externally applied light. Hydrogels are formed with polyethylene glycol and heparin-based polymers using a Michael-type addition reaction. The resulting hydrogels are investigated for the local controlled release of low molecular weight proteins (e.g., growth factors and cytokines), which are of interest for regulating various cellular functions and fates in vivo yet remain difficult to deliver. Incorporation of reduction-sensitive linkages and light-degradable linkages affords significant changes in the release profiles of fibroblast growth factor-2 (FGF-2) in the presence of the reducing agent glutathione or light, respectively. The bioactivity of the released FGF-2 is comparable to pristine FGF-2, indicating the ability of these hydrogels to retain the bioactivity of cargo molecules during encapsulation and release. Further, in vivo studies demonstrate degradation-mediated release of FGF-2. Overall, our studies demonstrate the potential of these unique stimuli-responsive chemistries for controlling the local release of low molecular weight proteins in response to clinically relevant stimuli.

AB - Injectable delivery systems that respond to biologically relevant stimuli present an attractive strategy for tailorable drug release. Here, the design and synthesis of unique polymers are reported for the creation of hydrogels that are formed in situ and degrade in response to clinically relevant endogenous and exogenous stimuli, specifically reducing microenvironments and externally applied light. Hydrogels are formed with polyethylene glycol and heparin-based polymers using a Michael-type addition reaction. The resulting hydrogels are investigated for the local controlled release of low molecular weight proteins (e.g., growth factors and cytokines), which are of interest for regulating various cellular functions and fates in vivo yet remain difficult to deliver. Incorporation of reduction-sensitive linkages and light-degradable linkages affords significant changes in the release profiles of fibroblast growth factor-2 (FGF-2) in the presence of the reducing agent glutathione or light, respectively. The bioactivity of the released FGF-2 is comparable to pristine FGF-2, indicating the ability of these hydrogels to retain the bioactivity of cargo molecules during encapsulation and release. Further, in vivo studies demonstrate degradation-mediated release of FGF-2. Overall, our studies demonstrate the potential of these unique stimuli-responsive chemistries for controlling the local release of low molecular weight proteins in response to clinically relevant stimuli.

KW - Biologics delivery

KW - Controlled release

KW - Injectable hydrogel

KW - Responsive materials

UR - http://www.scopus.com/inward/record.url?scp=85031395320&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85031395320&partnerID=8YFLogxK

U2 - 10.1002/adhm.201700713

DO - 10.1002/adhm.201700713

M3 - Article

C2 - 29024487

AN - SCOPUS:85031395320

JO - Advanced healthcare materials

JF - Advanced healthcare materials

SN - 2192-2640

ER -